• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

长链非编码 RNA SAMMSON 通过 p300/Sp1 轴促进甲状腺乳头状癌的进展,并作为一种新的诊断和预后生物标志物。

Long noncoding RNA SAMMSON promotes papillary thyroid carcinoma progression through p300/Sp1 axis and serves as a novel diagnostic and prognostic biomarker.

机构信息

Department of Thyroid Surgery, The First Hospital of China Medical University, Shenyang, People's Republic of China.

出版信息

IUBMB Life. 2020 Feb;72(2):237-246. doi: 10.1002/iub.2158. Epub 2019 Sep 3.

DOI:10.1002/iub.2158
PMID:31478331
Abstract

Accumulating evidence suggests that long noncoding RNA (lncRNA) plays a fundamental role in cancer progression. However, its biological function in papillary thyroid carcinoma (PTC) has not been fully elucidated. Here, we deciphered the essential role of lncRNA SAMMSON in PTC. SAMMSON was identified to be notably upregulated in PTC cells, tissues, and plasma, and could be used as an effective diagnostic and prognostic biomarker for PTC patients. Knockdown of SAMMSON significantly inhibited PTC cell proliferation and invasion in vitro as well as tumorigenicity and metastasis in vivo. Mechanistically, SAMMSON was transcriptionally elevated by oncogenic Sp1, in turn, upregulated SAMMSON was capable of acting as a scaffold to recruit p300 to increase H3K9ac and H3K27ac levels on Sp1 promoter region, leading to transcriptional activation of Sp1, thereby facilitating PTC progression. Taken together, our data demonstrate that SAMMSON is an oncogenic lncRNA and unveil the crucial role of SAMMSON/Sp1 positive feedback loop in tumorigenesis and aggressiveness of PTC.

摘要

越来越多的证据表明,长非编码 RNA(lncRNA)在癌症进展中起着至关重要的作用。然而,其在甲状腺乳头状癌(PTC)中的生物学功能尚未完全阐明。在这里,我们揭示了 lncRNA SAMMSON 在 PTC 中的重要作用。SAMMSON 在 PTC 细胞、组织和血浆中明显上调,可作为 PTC 患者有效的诊断和预后生物标志物。SAMMSON 的敲低显著抑制了 PTC 细胞在体外的增殖和侵袭,以及体内的致瘤性和转移。从机制上讲,致癌 Sp1 转录上调 SAMMSON,反过来,上调的 SAMMSON 能够作为支架招募 p300,增加 Sp1 启动子区域上的 H3K9ac 和 H3K27ac 水平,导致 Sp1 的转录激活,从而促进 PTC 的进展。总之,我们的数据表明 SAMMSON 是一种致癌 lncRNA,并揭示了 SAMMSON/Sp1 正反馈环在 PTC 发生和侵袭性中的关键作用。

相似文献

1
Long noncoding RNA SAMMSON promotes papillary thyroid carcinoma progression through p300/Sp1 axis and serves as a novel diagnostic and prognostic biomarker.长链非编码 RNA SAMMSON 通过 p300/Sp1 轴促进甲状腺乳头状癌的进展,并作为一种新的诊断和预后生物标志物。
IUBMB Life. 2020 Feb;72(2):237-246. doi: 10.1002/iub.2158. Epub 2019 Sep 3.
2
Long non-coding RNA ASMTL-AS1 inhibits tumor growth and glycolysis by regulating the miR-93-3p/miR-660/FOXO1 axis in papillary thyroid carcinoma.长链非编码 RNA ASMTL-AS1 通过调控 miR-93-3p/miR-660/FOXO1 轴抑制甲状腺乳头状癌肿瘤生长和糖酵解。
Life Sci. 2020 Mar 1;244:117298. doi: 10.1016/j.lfs.2020.117298. Epub 2020 Jan 14.
3
Positive feedback loop SP1/SNHG1/miR-199a-5p promotes the malignant properties of thyroid cancer.正反馈环 SP1/SNHG1/miR-199a-5p 促进甲状腺癌的恶性特性。
Biochem Biophys Res Commun. 2020 Feb 12;522(3):724-730. doi: 10.1016/j.bbrc.2019.11.075. Epub 2019 Nov 30.
4
BGL3 inhibits papillary thyroid carcinoma progression via regulating PTEN stability.BGL3 通过调控 PTEN 稳定性抑制甲状腺乳头状癌细胞的进展。
J Endocrinol Invest. 2021 Oct;44(10):2165-2174. doi: 10.1007/s40618-021-01519-2. Epub 2021 Feb 4.
5
SP1-induced upregulation of long noncoding RNA LINC00313 contributes to papillary thyroid cancer progression via the miR-422a.SP1 诱导的长链非编码 RNA LINC00313 的上调通过 miR-422a 促进甲状腺乳头状癌的进展。
Eur Rev Med Pharmacol Sci. 2019 Feb;23(3):1134-1144. doi: 10.26355/eurrev_201902_17004.
6
LncRNA HOTTIP promotes papillary thyroid carcinoma cell proliferation, invasion and migration by regulating miR-637.长链非编码 RNA HOTTIP 通过调节 miR-637 促进甲状腺乳头状癌细胞的增殖、侵袭和迁移。
Int J Biochem Cell Biol. 2018 May;98:1-9. doi: 10.1016/j.biocel.2018.02.013. Epub 2018 Feb 21.
7
Long noncoding RNA cancer susceptibility candidate 2 suppresses papillary thyroid carcinoma growth by inactivating the AKT/ERK1/2 signaling pathway.长链非编码 RNA 癌症易感性候选基因 2 通过失活 AKT/ERK1/2 信号通路抑制甲状腺乳头状癌生长。
J Cell Biochem. 2019 Jun;120(6):10380-10390. doi: 10.1002/jcb.28322. Epub 2019 Jan 4.
8
STAT3-induced upregulation of lncRNA ABHD11-AS1 promotes tumour progression in papillary thyroid carcinoma by regulating miR-1301-3p/STAT3 axis and PI3K/AKT signalling pathway.STAT3 诱导的长链非编码 RNA ABHD11-AS1 的上调通过调节 miR-1301-3p/STAT3 轴和 PI3K/AKT 信号通路促进甲状腺乳头状癌的肿瘤进展。
Cell Prolif. 2019 Mar;52(2):e12569. doi: 10.1111/cpr.12569. Epub 2019 Jan 18.
9
A novel lncRNA n384546 promotes thyroid papillary cancer progression and metastasis by acting as a competing endogenous RNA of miR-145-5p to regulate AKT3.一种新的长链非编码 RNA n384546 通过作为 miR-145-5p 的竞争性内源性 RNA 来调节 AKT3,促进甲状腺乳头状癌的进展和转移。
Cell Death Dis. 2019 Jun 3;10(6):433. doi: 10.1038/s41419-019-1637-7.
10
circ_0005273 promotes thyroid carcinoma progression by SOX2 expression.circ_0005273 通过 SOX2 表达促进甲状腺癌进展。
Endocr Relat Cancer. 2020 Jan;27(1):11-21. doi: 10.1530/ERC-19-0381.

引用本文的文献

1
Novel insights into lncRNAs as key regulators of post-translational modifications in cancer: mechanisms and therapeutic potential.长链非编码RNA作为癌症中翻译后修饰关键调节因子的新见解:机制与治疗潜力
Cell Oncol (Dordr). 2025 Jul 2. doi: 10.1007/s13402-025-01086-1.
2
lncRNA Biomarkers of Glioblastoma Multiforme.多形性胶质母细胞瘤的长链非编码RNA生物标志物
Biomedicines. 2024 Apr 23;12(5):932. doi: 10.3390/biomedicines12050932.
3
The oncogenic role of SAMMSON lncRNA in tumorigenesis: A comprehensive review with especial focus on melanoma.
SAMMSON lncRNA 在肿瘤发生中的致癌作用:全面综述,特别关注黑色素瘤。
J Cell Mol Med. 2023 Dec;27(24):3966-3973. doi: 10.1111/jcmm.17978. Epub 2023 Sep 29.
4
Bioinformatic Identification of Potential RNA Alterations on the Atrial Fibrillation Remodeling from Human Pulmonary Veins.从人肺静脉中鉴定心房颤动重构的潜在 RNA 改变的生物信息学方法。
Int J Mol Sci. 2023 Jun 22;24(13):10501. doi: 10.3390/ijms241310501.
5
Specificity Proteins (Sp) and Cancer.特异性蛋白(Sp)与癌症。
Int J Mol Sci. 2023 Mar 8;24(6):5164. doi: 10.3390/ijms24065164.
6
Long Noncoding RNA SAMMSON Promotes Melanoma Progression by Inhibiting FOXA2 Expression.长链非编码RNA SAMMSON通过抑制FOXA2表达促进黑色素瘤进展。
Stem Cells Int. 2023 Feb 7;2023:8934210. doi: 10.1155/2023/8934210. eCollection 2023.
7
Long noncoding RNA lncMREF promotes myogenic differentiation and muscle regeneration by interacting with the Smarca5/p300 complex.长非编码 RNA lncMREF 通过与 Smarca5/p300 复合物相互作用促进成肌分化和肌肉再生。
Nucleic Acids Res. 2022 Oct 14;50(18):10733-10755. doi: 10.1093/nar/gkac854.
8
CRNDE acts as an epigenetic modulator of the p300/YY1 complex to promote HCC progression and therapeutic resistance.CRNDE 作为 p300/YY1 复合物的表观遗传调节剂,促进 HCC 进展和治疗耐药性。
Clin Epigenetics. 2022 Aug 23;14(1):106. doi: 10.1186/s13148-022-01326-3.
9
Long non-coding RNA LINC01559 serves as a competing endogenous RNA accelerating triple-negative breast cancer progression.长链非编码 RNA LINC01559 作为竞争性内源性 RNA 加速三阴性乳腺癌进展。
Biomed J. 2022 Jun;45(3):512-521. doi: 10.1016/j.bj.2021.05.002. Epub 2021 May 29.
10
The Long Non-Coding RNA SAMMSON Is a Regulator of Chemosensitivity and Metabolic Orientation in MCF-7 Doxorubicin-Resistant Breast Cancer Cells.长链非编码RNA SAMMSON是MCF-7阿霉素耐药乳腺癌细胞中化学敏感性和代谢取向的调节因子。
Biology (Basel). 2021 Nov 9;10(11):1156. doi: 10.3390/biology10111156.